질경이 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by SBI인베스트먼트, was filed 16 Apr 2026.
질경이: what insiders have been doing
Every trade that managers of 질경이 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Between 1 November 2025 and 1 November 2026, 2 insiders published 10 filings.
The record shows 2 purchases on the open market, made by 2 insiders, against 6 sales by 1 insider. The totals do not cover 8 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 10 filings here. The full history, which starts in 2023, counts 4 purchases against 6 sales.
The last purchase on record was published on 16 April 2026, which is 208 days ago. Filings reach the DART (FSS) feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -24.2%Entry 1,848.00 · Close at T+90 1,400.00
- -14.3%Entry 699.00 · Close at T+365 599.00
- -14.3%Entry 699.00 · Close at T+365 599.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- Other0DART
- Other0DART
- Other0DART
- ShareKRXDART:20260528000132
- ShareKRXDART:20260528000295
- ShareKRXDART:20260421000457
- 1,363,636 sharesKRXDART:20260416000542Canonical exit: 10 Jul 2026 (T+90)
- ShareKRXDART:20260310002929
- ●Executives0DART
- 864,184 sharesKRXDART:20260107000346Canonical exit: 30 Mar 2026 (T+90)
- 555,000 sharesShareKRXDART:20260107000603
- 555,000 sharesShareKRXDART:20260107000368
- ●Executives0DART
- 417,750 shares@ ₩1,200.00100.0% of flowShareKRXDART:20230110000026Canonical exit: 3 Apr 2023 (T+90)
- 100,000 shares@ ₩1,200.00100.0% of flowShareKRXDART:20230110000197Canonical exit: 3 Apr 2023 (T+90)
15 of 15 declarations
About 질경이
질경이 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and marketing of health-related products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
